Skip to main content
Aprogen, Inc logo

Aprogen, Inc — Investor Relations & Filings

Ticker · 007460 ISIN · KR7007460009 KO Manufacturing
Open in API
Filings indexed 735 across all filing types
Latest filing 2022-04-18 Capital/Financing Update
Country KR South Korea
Listing KO 007460

About Aprogen, Inc

https://www.aprogen.com/en/v.do?a=Main

Aprogen, Inc. is a biopharmaceutical company focused on the research, development, and manufacturing of biologic medicines. The company's core activities are centered on developing both biosimilars and novel drugs, including new protein therapeutics and bispecific antibodies. Its product development is based on proprietary technologies in antibody engineering and recombinant protein engineering.

Recent filings

Filing Released Lang Actions
[기재정정]주요사항보고서(전환사채권발행결정)
Capital/Financing Update Classification · 100% confidence The document is a 'Major Matters Report' (주요사항보고서) regarding a correction (정정신고) to a previously filed Convertible Bond issuance (전환사채권 발행결정). It details specific changes to maturity dates, interest payment methods, and conversion terms. Since this document relates to the company's capital structure and financing activities (issuance of convertible bonds), it falls under the 'Capital/Financing Update' category.
2022-04-18 Korean
[기재정정]증권신고서(합병)
M&A Activity Classification · 100% confidence The document is a '증권신고서(합병) 정정신고' (Securities Registration Statement - Merger Amendment) filed by Aprogen Medicines. It details amendments to a previously filed merger registration statement, including changes to merger dates, share allocation schedules, and risk factors. In the context of financial filings, a merger registration statement and its subsequent amendments are classified under M&A Activity (TAR) as they pertain to the formal process of corporate consolidation.
2022-04-18 Korean
[기재정정]증권신고서(합병)
M&A Activity Classification · 100% confidence The document is a '증권신고서(합병) 정정신고' (Securities Registration Statement (Merger) Amendment) filed by Aprogen Medicines. It details multiple amendments to a previously filed merger registration statement, including updates to shareholding structures, valuation methodologies, and risk factors related to the merger. This falls under the category of M&A activity documentation.
2022-04-15 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report on Large Shareholding' (주식등의 대량보유상황보고서), which is a standard regulatory filing in South Korea (often referred to as a 5% rule filing). It details changes in share ownership, specifically involving convertible bonds and shareholdings by 'Cress Investment Association' in 'Aprogen Medicines'. This type of filing is a mandatory disclosure to the Financial Supervisory Service (FSS) and the Korea Exchange (KRX) when a party crosses a significant ownership threshold. It falls under the 'Major Shareholding Notification' category.
2022-04-14 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Large Shareholding' (주식등의 대량보유상황보고서), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership by a major shareholder (G-BAISE Inc.) and its special related parties in the company Aprogen Medicines. This type of filing is specifically used to notify the market and regulators when a shareholder crosses significant ownership thresholds or changes their holdings, which falls under the 'Major Shareholding Notification' category.
2022-04-13 Korean
주주총회소집결의
AGM Information Classification · 98% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집결의) issued by Aprogen MED. It outlines the date, location, and agenda items (such as financial statement approval, director appointments, and remuneration limits) for the upcoming meeting. This type of document is a standard proxy solicitation or notice of meeting sent to shareholders to inform them of the meeting and request their participation/votes, which falls under the Proxy Solicitation & Information Statement category.
2022-04-13 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.